Evidence map›Paper›PMID 41578971›Full record

ArticleProtein science : a publication of the Protein Society2026

Guiding AlphaFold predictions with experimental knowledge to inform dynamics and interactions with VAIRO.

Josep Triviño, Elisabet Jiménez, Christoph Grininger, Iracema Caballero, Ana Medina, Albert Castellví, Giovanna Petrillo, Fernando Govantes, Theo Sagmeister, Martín Alcorlo and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Josep TriviñoDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Elisabet JiménezDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Christoph GriningerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Iracema CaballeroDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Ana MedinaDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Albert CastellvíDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Giovanna PetrilloDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Fernando GovantesCentro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide/Consejo Superior de Investigaciones Científicas/Junta de Andalucía, Sevilla, Spain.
Theo SagmeisterInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Martín AlcorloDepartment of Crystallography and Structural Biology, Institute of Physical-Chemistry Blas Cabrera (IQF-CSIC), Madrid, Spain.
Juan A HermosoDepartment of Crystallography and Structural Biology, Institute of Physical-Chemistry Blas Cabrera (IQF-CSIC), Madrid, Spain.
Massimo D SammitoDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
Kay DiederichsFachbereich Biologie, Universität Konstanz, Constance, Germany.ORCID https://orcid.org/0000-0001-5360-0905
Tea Pavkov-KellerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Isabel UsónDepartment of Structural Biology, Instituto de Biología Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.ORCID https://orcid.org/0000-0003-2504-1696

Funding

Austrian Science FundDoctoral Academy Graz (BioMolStruct Consortium)Ministerio de Ciencia, Innovación y Universidades BES-2017-080368Ministerio de Ciencia, Innovación y Universidades MDM2014-0435-01Ministerio de Ciencia, Innovación y Universidades PGC2018-101370-B-I00Ministerio de Ciencia, Innovación y Universidades PID2020-115331GB-I00Ministerio de Ciencia, Innovación y Universidades PID2021-128751NB-I00Ministerio de Ciencia, Innovación y Universidades PRE2019-087953Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung CRSII5_198737/1Science and Technology Facilities Council CCP4-ARCIMBOLDO_LOW
6 · The paper itself

Abstract

Structural predictions have reached unprecedented accuracy. They leverage sequence-specific data to capture all potential interactions a sequence has evolved to fulfill. AlphaFold derives information from three sources: learned parameters capturing intrinsic amino acid secondary structure and environment propensity; models of related proteins providing structural templates; and aligned sequences encoding profiles and concerted evolutionary changes of residues involved in contacts. However, function demands dynamic changes; hence not all possible interactions can coexist simultaneously. Comprehensive information entails contradictions, which resolved in favor of the better-informed structure will silence less stable states and associations. Here, we introduce a method using all three channels to include prior knowledge: site-specific variants, predefined alignments and templates. Selecting information relevant to a particular state delimits the functional context of a prediction. Our program VAIRO allows us to rescue asymmetric and weaker interactions to complete the view of molecular assemblies in the architecture of a bacterial surface layer, and reveals otherwise inaccessible dynamic states in a pneumococcal multimeric membrane protein complex. VAIRO is distributed via the python package index (PyPI) (https://pypi.org/project/vairo) and the code is also available on Github (https://github.com/arcimboldo-team/vairo).

Indexed as

Bacterial ProteinsSoftwareModels, MolecularProtein FoldingProtein Structure, SecondaryStreptococcus pneumoniaeBacterial ProteinsABC transporterAlphaFoldbacterial surface layerdynamicsinteractionspredictionsstructureVAIRO

Identifiers

PMID41578971
PMCPMC12831285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.